ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI spots hidden heart risk in routine scans – 120,000 patients join study
Disease control Not yet recruitingThis study uses artificial intelligence to find calcium buildup in heart arteries on chest CT scans that people already had for other reasons. Researchers will notify patients and their doctors about the finding to encourage better cholesterol treatment. The goal is to see if thi…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated May 17, 2026 15:38 UTC
-
New drug aims to treat two conditions at once: heart disease and erectile dysfunction
Disease control Not yet recruitingThis study tests a new medicine called YN001 in 40 people who have both heart or blood vessel disease and erectile dysfunction. The goal is to see if the drug improves erectile function and reduces thickening of the carotid artery. Participants will be randomly assigned to receiv…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 15:35 UTC
-
Can a smartphone app help control cholesterol and blood pressure?
Disease control Not yet recruitingThis study will test a new way to manage heart disease risk using a digital, nurse-led remote monitoring program. About 750 adults with heart disease or related conditions will use home devices to track their cholesterol and blood pressure. The goal is to see if this approach hel…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Double-Barreled cholesterol attack: new combo trial for Statin-Intolerant patients
Disease control Not yet recruitingThis study tests whether combining two cholesterol-lowering drugs (inclisiran and alirocumab) works better than either drug alone. About 60 adults with high heart risk who cannot take statins will receive one or both drugs for 9 months. The goal is to see if the combo lowers 'bad…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: PHASE4 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated May 13, 2026 16:01 UTC